As many as 45% of patients with gastroesophageal reflux disease (GERD) still have symptoms after receiving a once-daily proton pump inhibitor (PPI) therapy. A recent study by Jason Abdallah and colleagues at MetroHealth Medical Center, Case Western Reserve University School of Medicine, utilized survey, pH, and other data. Although a small trial, the findings showed
